Northern Trust
RUBY

Northern Trust’s Rubius Therapeutics, Inc RUBY Stock Holding History

Northern Trust’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-71,366
Closed -$12.5K – 4663
2022
Q4 		$12.5K Sell
71,366
-127
-0.2% -$35 ﹤0.01% 4547
2022
Q3 		$31K Hold
71,493
– – ﹤0.01% 4457
2022
Q2 		$61K Sell
71,493
-341,032
-83% -$572K ﹤0.01% 4346
2022
Q1 		$2.27M Sell
412,525
-23,152
-5% -$147K ﹤0.01% 3037
2021
Q4 		$4.22M Sell
435,677
-12,782
-3% -$177K ﹤0.01% 2796
2021
Q3 		$8.02M Sell
448,459
-26,382
-6% -$574K ﹤0.01% 2443
2021
Q2 		$11.6M Buy
474,841
+77,428
+19% +$1.94M ﹤0.01% 2267
2021
Q1 		$10.5M Sell
397,413
-12,611
-3% -$184K ﹤0.01% 2252
2020
Q4 		$3.11M Sell
410,024
-10,848
-3% -$64.4K ﹤0.01% 2953
2020
Q3 		$2.11M Sell
420,872
-17,575
-4% -$93.1K ﹤0.01% 3038
2020
Q2 		$2.62M Sell
438,447
-14,866
-3% -$87.8K ﹤0.01% 2888
2020
Q1 		$2.02M Buy
453,313
+6,665
+1% +$49.5K ﹤0.01% 2852
2019
Q4 		$4.24M Sell
446,648
-785
-0.2% -$7.59K ﹤0.01% 2684
2019
Q3 		$3.51M Buy
447,433
+67,516
+18% +$787K ﹤0.01% 2759
2019
Q2 		$5.98M Buy
379,917
+12,753
+3% +$206K ﹤0.01% 2461
2019
Q1 		$6.64M Buy
367,164
+195,919
+114% +$3.01M ﹤0.01% 2381
2018
Q4 		$2.75M Buy
171,245
+36,674
+27% +$669K ﹤0.01% 2871
2018
Q3 		$3.23M Buy
+134,571
New +$3.08M ﹤0.01% 2948

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Northern Trust's RUBY Position: Q1 2023 in Review

Northern Trust sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 71,366 shares — an estimated $12.5K sold.

Northern Trust first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $11.6M in Q2 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Northern Trust reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 71,366 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $12.5K.
  • Northern Trust first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Northern Trust's Rubius Therapeutics, Inc position peaked at $11.6M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.